 | • レポートコード：MRC2-11QY04152 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はパニック障害のグローバル市場について調査・分析したレポートです。種類別（抗うつ剤、ベンゾジアゼピン）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別パニック障害の競争状況、市場シェア ・世界のパニック障害市場：種類別市場規模 2015年-2020年（抗うつ剤、ベンゾジアゼピン） ・世界のパニック障害市場：種類別市場規模予測 2021年-2026年（抗うつ剤、ベンゾジアゼピン） ・世界のパニック障害市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、Eコマース） ・世界のパニック障害市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、Eコマース） ・北米のパニック障害市場分析：米国、カナダ ・ヨーロッパのパニック障害市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのパニック障害市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のパニック障害市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのパニック障害市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceutical、Sun Pharmaceuticals、Mylan、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.
Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used include antidepressants and occasionally benzodiazepines or beta blockers.
Market Analysis and Insights: Global Panic Disorders Market
The global Panic Disorders market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Panic Disorders Scope and Market Size
Panic Disorders market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Panic Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Teva Pharmaceutical
Sun Pharmaceuticals
Mylan
AstraZeneca
…
Market segment by Type, the product can be split into
Anti-Depressants
Benzodiazepines
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Panic Disorders Revenue
1.4 Market by Type
1.4.1 Global Panic Disorders Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-Depressants
1.4.3 Benzodiazepines
1.5 Market by Application
1.5.1 Global Panic Disorders Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Panic Disorders Market Perspective (2015-2026)
2.2 Global Panic Disorders Growth Trends by Regions
2.2.1 Panic Disorders Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Panic Disorders Historic Market Share by Regions (2015-2020)
2.2.3 Panic Disorders Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Panic Disorders Market Growth Strategy
2.3.6 Primary Interviews with Key Panic Disorders Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Panic Disorders Players by Market Size
3.1.1 Global Top Panic Disorders Players by Revenue (2015-2020)
3.1.2 Global Panic Disorders Revenue Market Share by Players (2015-2020)
3.1.3 Global Panic Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Panic Disorders Market Concentration Ratio
3.2.1 Global Panic Disorders Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Panic Disorders Revenue in 2019
3.3 Panic Disorders Key Players Head office and Area Served
3.4 Key Players Panic Disorders Product Solution and Service
3.5 Date of Enter into Panic Disorders Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Panic Disorders Historic Market Size by Type (2015-2020)
4.2 Global Panic Disorders Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Panic Disorders Market Size by Application (2015-2020)
5.2 Global Panic Disorders Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Panic Disorders Market Size (2015-2020)
6.2 Panic Disorders Key Players in North America (2019-2020)
6.3 North America Panic Disorders Market Size by Type (2015-2020)
6.4 North America Panic Disorders Market Size by Application (2015-2020)
7 Europe
7.1 Europe Panic Disorders Market Size (2015-2020)
7.2 Panic Disorders Key Players in Europe (2019-2020)
7.3 Europe Panic Disorders Market Size by Type (2015-2020)
7.4 Europe Panic Disorders Market Size by Application (2015-2020)
8 China
8.1 China Panic Disorders Market Size (2015-2020)
8.2 Panic Disorders Key Players in China (2019-2020)
8.3 China Panic Disorders Market Size by Type (2015-2020)
8.4 China Panic Disorders Market Size by Application (2015-2020)
9 Japan
9.1 Japan Panic Disorders Market Size (2015-2020)
9.2 Panic Disorders Key Players in Japan (2019-2020)
9.3 Japan Panic Disorders Market Size by Type (2015-2020)
9.4 Japan Panic Disorders Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Panic Disorders Market Size (2015-2020)
10.2 Panic Disorders Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Panic Disorders Market Size by Type (2015-2020)
10.4 Southeast Asia Panic Disorders Market Size by Application (2015-2020)
11 India
11.1 India Panic Disorders Market Size (2015-2020)
11.2 Panic Disorders Key Players in India (2019-2020)
11.3 India Panic Disorders Market Size by Type (2015-2020)
11.4 India Panic Disorders Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Panic Disorders Market Size (2015-2020)
12.2 Panic Disorders Key Players in Central & South America (2019-2020)
12.3 Central & South America Panic Disorders Market Size by Type (2015-2020)
12.4 Central & South America Panic Disorders Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Details
13.1.2 Teva Pharmaceutical Business Overview
13.1.3 Teva Pharmaceutical Panic Disorders Introduction
13.1.4 Teva Pharmaceutical Revenue in Panic Disorders Business (2015-2020))
13.1.5 Teva Pharmaceutical Recent Development
13.2 Sun Pharmaceuticals
13.2.1 Sun Pharmaceuticals Company Details
13.2.2 Sun Pharmaceuticals Business Overview
13.2.3 Sun Pharmaceuticals Panic Disorders Introduction
13.2.4 Sun Pharmaceuticals Revenue in Panic Disorders Business (2015-2020)
13.2.5 Sun Pharmaceuticals Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Panic Disorders Introduction
13.3.4 Mylan Revenue in Panic Disorders Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Panic Disorders Introduction
13.4.4 AstraZeneca Revenue in Panic Disorders Business (2015-2020)
13.4.5 AstraZeneca Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Panic Disorders Key Market Segments
Table 2. Key Players Covered: Ranking by Panic Disorders Revenue
Table 3. Ranking of Global Top Panic Disorders Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Panic Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-Depressants
Table 6. Key Players of Benzodiazepines
Table 7. Global Panic Disorders Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Panic Disorders Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Panic Disorders Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Panic Disorders Market Share by Regions (2015-2020)
Table 11. Global Panic Disorders Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Panic Disorders Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Panic Disorders Market Growth Strategy
Table 17. Main Points Interviewed from Key Panic Disorders Players
Table 18. Global Panic Disorders Revenue by Players (2015-2020) (Million US$)
Table 19. Global Panic Disorders Market Share by Players (2015-2020)
Table 20. Global Top Panic Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panic Disorders as of 2019)
Table 21. Global Panic Disorders by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Panic Disorders Product Solution and Service
Table 24. Date of Enter into Panic Disorders Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 27. Global Panic Disorders Market Size Share by Type (2015-2020)
Table 28. Global Panic Disorders Revenue Market Share by Type (2021-2026)
Table 29. Global Panic Disorders Market Size Share by Application (2015-2020)
Table 30. Global Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 31. Global Panic Disorders Market Size Share by Application (2021-2026)
Table 32. North America Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Panic Disorders Market Share (2019-2020)
Table 34. North America Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 35. North America Panic Disorders Market Share by Type (2015-2020)
Table 36. North America Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 37. North America Panic Disorders Market Share by Application (2015-2020)
Table 38. Europe Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Panic Disorders Market Share (2019-2020)
Table 40. Europe Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Panic Disorders Market Share by Type (2015-2020)
Table 42. Europe Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Panic Disorders Market Share by Application (2015-2020)
Table 44. China Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 45. China Key Players Panic Disorders Market Share (2019-2020)
Table 46. China Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 47. China Panic Disorders Market Share by Type (2015-2020)
Table 48. China Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 49. China Panic Disorders Market Share by Application (2015-2020)
Table 50. Japan Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Panic Disorders Market Share (2019-2020)
Table 52. Japan Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Panic Disorders Market Share by Type (2015-2020)
Table 54. Japan Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Panic Disorders Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Panic Disorders Market Share (2019-2020)
Table 58. Southeast Asia Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Panic Disorders Market Share by Type (2015-2020)
Table 60. Southeast Asia Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Panic Disorders Market Share by Application (2015-2020)
Table 62. India Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 63. India Key Players Panic Disorders Market Share (2019-2020)
Table 64. India Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 65. India Panic Disorders Market Share by Type (2015-2020)
Table 66. India Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 67. India Panic Disorders Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Panic Disorders Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Panic Disorders Market Share (2019-2020)
Table 70. Central & South America Panic Disorders Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Panic Disorders Market Share by Type (2015-2020)
Table 72. Central & South America Panic Disorders Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Panic Disorders Market Share by Application (2015-2020)
Table 74. Teva Pharmaceutical Company Details
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Product
Table 77. Teva Pharmaceutical Revenue in Panic Disorders Business (2015-2020) (Million US$)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Sun Pharmaceuticals Company Details
Table 80. Sun Pharmaceuticals Business Overview
Table 81. Sun Pharmaceuticals Product
Table 82. Sun Pharmaceuticals Revenue in Panic Disorders Business (2015-2020) (Million US$)
Table 83. Sun Pharmaceuticals Recent Development
Table 84. Mylan Company Details
Table 85. Mylan Business Overview
Table 86. Mylan Product
Table 87. Mylan Revenue in Panic Disorders Business (2015-2020) (Million US$)
Table 88. Mylan Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Product
Table 92. AstraZeneca Revenue in Panic Disorders Business (2015-2020) (Million US$)
Table 93. AstraZeneca Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Panic Disorders Market Share by Type: 2020 VS 2026
Figure 2. Anti-Depressants Features
Figure 3. Benzodiazepines Features
Figure 4. Global Panic Disorders Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. E-Commerce Case Studies
Figure 9. Panic Disorders Report Years Considered
Figure 10. Global Panic Disorders Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Panic Disorders Market Share by Regions: 2020 VS 2026
Figure 12. Global Panic Disorders Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Panic Disorders Market Share by Players in 2019
Figure 15. Global Top Panic Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panic Disorders as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Panic Disorders Revenue in 2019
Figure 17. North America Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Panic Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
不安障害・パニック障害用薬の世界市場（～2026年） Anxiety and Panic Disorders Drugs are two kinds of drugs which are usually used in respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal. During 2017, the anxiety and panic disorders antidepressant drugs segment con…- 骨・ミネラル代謝障害治療の世界市場（～2026年） Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…
- ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- ペプチド代謝障害治療薬の世界市場（～2026年） A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…
- 副甲状腺障害の世界市場（～2026年） Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems. Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hy…